Spots Global Cancer Trial Database for Exploratory Study on POL6326 in Stem Cell Mobilization
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Exploratory Study on POL6326 in Stem Cell Mobilization
Official Title: A Phase IIa, Proof of Concept Study is to Determine the Degree of Mobilisation of CD34+ Cells Following Administration of POL6326 in Patients With Multiple Myeloma
Study ID: NCT01105403
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine whether POL6326 is safe and clinically active to mobilize hematopoietic stem cells followed by transplantation
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Department of Internal Medicine V, Heidelberg, , Germany
Contact Details
Name: Hartmut Goldschmidt, MD
Affiliation: Heidelberg University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
